White H L, Stine D K
J Neurochem. 1984 Jun;42(6):1743-51. doi: 10.1111/j.1471-4159.1984.tb12766.x.
Human brain and liver mitochondria contain membrane-bound monoamine oxidase of both A and B types. Monamine oxidase-A (MAO-A), either membrane-bound or in detergent-solubilized extracts from these tissues, was selectively inhibited during incubations with trypsin, chymotrypsin, thermolysin, or papain. MAO-A in solubilized, but not in membrane-bound, preparations was also very sensitive to the action of phospholipase A2, while MAO-B was unaffected. Membrane-bound MAO-A of rat brain mitochondria was more sensitive to phospholipases and less sensitive to proteases than was human brain enzyme, indicating that these agents may reveal species differences in MAO properties. Human brain and liver MAO-A, either solubilized or bound in mitochondrial membranes, apparently contains basic and aromatic peptide moieties that are available to proteases. Hydrolysis of these peptide bonds leads to rapid denaturation unless substrate molecules stabilize the active site. Phospholipase A2 may disrupt the phospholipid microenvironment of MAO-A, the integrity of which is essential for MAO-A activity, but not for MAO-B. No interconversion of the two activities was observed. After phospholipase A2 treatment, remaining MAO-A activity was recovered in low-molecular-weight regions of a gel filtration gradient, suggesting that MAO-A subunits were released. Although these experiments argue against the proposal that phospholipids may regulate the ratio of A/B activities of a single enzyme molecule, it is conceivable that endogenous phospholipases or proteases in mitochondrial membranes may influence MAO-A activity independently of MAO-B activity.
人类大脑和肝脏线粒体含有A、B两种类型的膜结合单胺氧化酶。在与胰蛋白酶、胰凝乳蛋白酶、嗜热菌蛋白酶或木瓜蛋白酶孵育期间,膜结合的单胺氧化酶-A(MAO-A)或这些组织的去污剂增溶提取物中的MAO-A会被选择性抑制。增溶制剂中的MAO-A(而非膜结合制剂中的MAO-A)对磷脂酶A2的作用也非常敏感,而MAO-B则不受影响。大鼠脑线粒体的膜结合MAO-A比人脑酶对磷脂酶更敏感,对蛋白酶更不敏感,这表明这些试剂可能揭示MAO特性的物种差异。人脑中的MAO-A和肝脏中的MAO-A,无论是增溶的还是结合在线粒体膜中的,显然都含有蛋白酶可作用的碱性和芳香族肽部分。除非底物分子稳定活性位点,否则这些肽键的水解会导致快速变性。磷脂酶A2可能会破坏MAO-A的磷脂微环境,其完整性对MAO-A活性至关重要,但对MAO-B活性则不然。未观察到两种活性的相互转化。磷脂酶A2处理后,剩余的MAO-A活性在凝胶过滤梯度的低分子量区域中恢复,这表明MAO-A亚基被释放。尽管这些实验反对磷脂可能调节单个酶分子A/B活性比例的提议,但可以想象线粒体膜中的内源性磷脂酶或蛋白酶可能独立于MAO-B活性影响MAO-A活性。